课题基金 / 基金详情

泛素化酶WWP1在肠道炎性微环境中调控肠上皮细胞凋亡及恶性转化的作用机制研究

批准号:
82072750
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
张卫
学科分类:
肿瘤预防
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
张卫

项目摘要

结项摘要

张卫的其他基金

相似基金

相关文献

中文摘要
炎症相关的肠上皮细胞凋亡抵抗及恶性转化是结直肠癌发生的重要机制之一,其分子调控通路和关键靶点有待阐明。WWP1是一种与多种肿瘤发生相关的泛素化酶,我们前期报导了WWP1在结直肠癌组织中高表达并参与结直肠癌的进展,但其在结直肠癌发生中的作用未知。据此我们在不同的WWP1敲除小鼠中分别进行AOM/DSS肠道炎症造模,发现WWP1全身敲除和肠上皮细胞特异性敲除均可导致肠上皮细胞凋亡增加且肿瘤形成减少。后续预实验提示WWP1可能通过结合Smad7调控TGF-β通路进而影响肠上皮细胞凋亡和肿瘤形成。据此,本课题拟系统性利用基因敲除细胞与小鼠等模型,以期阐明WWP1在炎性微环境中调控肠上皮细胞凋亡抵抗及恶性转化的作用机制,验证肠上皮细胞中WWP1的相互作用蛋白和泛素化调控机制及下游关键作用通路和靶点,并初步探索靶向抑制WWP1对干预结直肠癌发生的效果,进而为结直肠癌发生提出新的机制和揭示新的治疗靶点。
英文摘要
Inflammation-related intestinal epithelial cell apoptosis resistance and malignant transformation is one of the most important mechanisms of colorectal cancer, but its molecular mechanism and target proteins remain unclarified. WWP1 is a ubiquitinating enzyme associated with various tumors. In our previous study, we found that WWP1 was highly expressed in colorectal cancer and participated in tumor progression, but its role in the development of colorectal cancer is unknown. Therefore, we constructed AOM/DSS model to simulate the chronic intestinal inflammation in different WWP1 knockout mice. We found that both WWP1 systemic knockout and intestinal epithelial cell-specific knockout could lead to increased intestinal epithelial cell apoptosis and reduced tumor formation. Further studies suggested that WWP1 might regulate TGF-β signaling pathway and intestinal epithelial cell apoptosis by binding with Smad7. Therefore, by using gene knockout cells and mice and other in vivo and in vivo models, we aim to clarify the role of WWP1 in intestinal epithelial cell apoptosis resistance and malignant transformation in the inflammatory microenvironment, and to verify the target proteins of WWP1 in intestinal epithelial cells, and to propose new mechanisms and therapeutic targets for colorectal cancer.
蛋白酪氨酸磷酸酶SHP2可激活RAS信号传导,是结直肠癌(CRC)治疗的新靶点。然而,SHP2 抑制剂单药治疗对转移性CRC疗效欠佳,需采用联药方案。本研究旨在提高SHP2抑制剂的抗肿瘤疗效,并尝试探索SHP2抑制剂的耐药机制。结果显示,WWP1能促进CRC细胞的增殖,基因或药物抑制WWP1可增强SHP2抑制剂在体内外抑制肿瘤生长的作用,而且WWP1可能介导了SHP2抑制后AKT信号的反馈再激活。此外,纳入WWP1和SHP2的表达水平构建的列线图模型大大提高了对CRC患者预后预测的准确性。我们的研究结果表明,WWP1抑制剂与SHP2抑制剂存在协同作用,有望成为晚期CRC患者临床试验新的治疗方案。
DDX家族分子DDX39在结肠癌炎症和肿瘤发生中的作用和机制研究
Nlk经由Wnt通路调控EMT影响结直肠癌肝转移的分子机制研究
国内基金
海外基金